CDH1 and non-small cell lung carcinoma: As expected, a quantitative real-time polymerase chain reaction (qRT)-PCR analysis showed that TGF-β treatment reduced the mRNA levels of the epithelial marker CDH1 in NSCLC, whereas it increased the levels of the mesenchymal markers CDH2 and VIM in the tested lung cells.